Metformin use reduces risk of death for patients with COVID-19 and diabetes
Use of the diabetes drug metformin - before a diagnosis of COVID-19 - is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19. (Source: World Pharma News)
Source: World Pharma News - January 18, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Metformin use reduces risk of death for patients with COVID-19 and diabetes
(University of Alabama at Birmingham) Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19. This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 14, 2021 Category: Infectious Diseases Source Type: news

Granules gets American drug regulator's nod for diabetes management drug Metformin
The US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg, Granules said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Another Lot of Extended-Release Metformin Is Recalled in the US Another Lot of Extended-Release Metformin Is Recalled in the US
Adding to two lots recalled in November, Nostrum Laboratories has issued a voluntary recall for another lot of extended-release metformin 750 mg due to possible contamination with NDMA.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 7, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

More Metformin Is Recalled
Another Lot of Extended-Release Metformin Is Recalled in the US (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 7, 2021 Category: General Medicine Source Type: news

Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) have been found to con (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Can early drug intervention prevent weight gain in children with mental illness?
(University of Houston) A University of Houston pharmacological researcher believes that prescribing the drug Metformin for children and teens as soon as they are diagnosed with mental illnesses, like bipolar disorder and schizophrenia, may save them from gaining an enormous amount of weight. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 16, 2020 Category: International Medicine & Public Health Source Type: news

Metformin Use May Reduce Mortality in Women With COVID-19
WEDNESDAY, Dec. 9, 2020 -- For women with type 2 diabetes or obesity who are admitted to the hospital with COVID-19, metformin use is associated with significantly reduced mortality, according to a study published online Dec. 3 in The Lancet Healthy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2020 Category: Pharmaceuticals Source Type: news

Pilot Study Looks at Metformin in COVID-19 Pilot Study Looks at Metformin in COVID-19
Small RCT will look at whether metformin has an impact on COVID-19, starting with inflammatory markers and viral load, but hoping to expand to outcomes.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 7, 2020 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news

New studies show diabetes drug not proven to improve blood sugar control in pediatric patients
The FDA has approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in pediatric patients. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Study finds metformin reduced COVID-19 death risks in women
University of Minnesota Medical School and UnitedHealth Group (NYSE: UNH) researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients. Metformin is an established, generic medication for managing blood sugar levels in patients with type 2 diabetes. (Source: World Pharma News)
Source: World Pharma News - December 3, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Study finds metformin reduced COVID-19 death risks in women
(University of Minnesota Medical School) University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2020 Category: International Medicine & Public Health Source Type: news

Study: Taking common drugs linked to impaired microbiome health and increased risk of obesity and intestinal infections
(Natural News) Researchers from the University Medical Center Groningen and Maastricht University Medical Center in the Netherlands have found that 18 common drug categories can negatively impact the gut microbiome, the total population of microbes present in the gut and their collective genetic material. Many of these drugs, such as the diabetes drug metformin and the antidepressant selective... (Source: NaturalNews.com)
Source: NaturalNews.com - November 25, 2020 Category: Consumer Health News Source Type: news

Metformin Improves Most Outcomes for T2D During Pregnancy Metformin Improves Most Outcomes for T2D During Pregnancy
Women with type 2 diabetes require fewer insulin doses and have a lower birthweight baby if they take metformin during pregnancy, one of the first randomized controlled trials to assess this shows.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 20, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Metformin for Diabetes During Pregnancy
Metformin Improves Most Outcomes for Diabetes During Pregnancy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 20, 2020 Category: General Medicine Source Type: news

Some Types of Metformin Recalled Due to Cancer Risk
Experts explain the back-and-forth on this popular diabetes drug ... If you take metformin to help manage diabetes, take note: Despite recent warnings and partial recalls by the Food and Drug Admin... (Source: AARP.org News)
Source: AARP.org News - November 16, 2020 Category: American Health Source Type: news

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 3, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg have been found to contain levels of nitrosamine impurities above the ADI limit (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 17, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Use of Common Meds Tied to Lower Lung Cancer Mortality
FRIDAY, Oct. 16, 2020 -- Use of aspirin, metformin, and statins is associated with a lower risk for lung cancer mortality, according to a study published online Sept. 17 in the Journal of Thoracic Oncology. Jihun Kang, M.D., from Kosin University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Hidradenitis Suppurativa Therapy Options Should Be Patient Guided Hidradenitis Suppurativa Therapy Options Should Be Patient Guided
A modern approach to hidradenitis suppurativa that incorporates such strategies as lasers, marsupialization, and metformin is built on a strategy individualized to the patient's most challenging symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

Recall Widens for Diabetes Drug Metformin Recall Widens for Diabetes Drug Metformin
More than 175 different drug combinations have been recalled since late May.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Recall Widens for Diabetes Drug Metformin
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 13, 2020 Category: General Medicine Source Type: news

Sun Pharma recalls 747 bottles of generic diabetes drug from the American market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Sun Pharmaceutical Industries is recalling the bottles of RIOMET ER (metformin hydrochloride for extended-release oral suspension) in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

'Don't panic.' Anti-diabetes medication recalled, may contain high levels of cancer-causing compound
Marksans Pharma and Sun Pharmaceutical Industries recalled metformin this week due to high levels of a cancer-causing compound,... (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2020 Category: Consumer Health News Source Type: news

Widely Used Diabetes Drug Recalled For High Levels Of Cancer-Causing Agent
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p2").init({"mcp":"cbs","width":"100%","height":"100%","video":"4777335","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p2","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 9, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Diabetes Recall Source Type: news

Metformin Linked to Reduced Cognitive Decline, Dementia Risk Metformin Linked to Reduced Cognitive Decline, Dementia Risk
Rates of dementia, cognitive decline in people with type 2 diabetes taking metformin were similar to those without diabetes.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - October 7, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg,& 750mg to the consumer level. Marksans performed N-Nitrosodimethylamine (NDMA) testing of (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

University of Minnesota receives seed funding for clinical study of metformin to treat, prevent COVID-19
(University of Minnesota Medical School) University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2020 Category: International Medicine & Public Health Source Type: news

Diabetes Drug Metformin May Protect Aging Brains
Title: Diabetes Drug Metformin May Protect Aging BrainsCategory: Health NewsCreated: 9/23/2020 12:00:00 AMLast Editorial Review: 9/24/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - September 24, 2020 Category: Endocrinology Source Type: news

Diabetes Drug Metformin May Protect Aging Brains
New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as they age. (Source: WebMD Health)
Source: WebMD Health - September 23, 2020 Category: Consumer Health News Source Type: news

Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER ™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER ™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Metformin May Slow Cognitive Decline in Seniors With T2DM
Cognitive decline slower, dementia risk reduced in seniors with diabetes receiving metformin (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 23, 2020 Category: Psychiatry Tags: Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Neurology, Pharmacy, Psychiatry, Radiology, Journal, Source Type: news

Metformin May Slow Cognitive Decline in Seniors With T2DM
WEDNESDAY, Sept. 23, 2020 -- For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study published online Sept. 23 in Diabetes Care. Katherine Samaras, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Diabetes Drug Metformin May Protect the Aging Brain
WEDNESDAY, Sept. 23, 2020 -- A common type 2 diabetes drug called metformin may have an unexpected, but positive, side effect: New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 23, 2020 Category: General Medicine Source Type: news

Three-drug combo reduces risk for lung cancer by 17%, study finds
Taking aspirin, statins and the drug metformin together reduces the risk for lung cancer by 17%, a study published Thursday by the Journal of Thoracic Oncology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 17, 2020 Category: Consumer Health News Source Type: news

Three common medications lower risk and mortality for lung cancer
(International Association for the Study of Lung Cancer) Combined use of aspirin, statins, and metformin is associated with decreased lung cancerincidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO). The JTO is the official journal of the International Association for the Study of Lung Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

How to mete out metformin
(Source: ScienceNOW)
Source: ScienceNOW - September 16, 2020 Category: Science Authors: Charneski, C. A. Tags: twis Source Type: news

Common diabetes drug reverses inflammation in the liver
(Salk Institute) The diabetes drug metformin has been prescribed to hundreds of millions of people worldwide as the frontline treatment for type 2 diabetes. Now, researchers at the Salk Institute have shown the importance of specific enzymes in the body for metformin's function. In addition, the new work showed that the same proteins, regulated by metformin, controlled aspects of inflammation in mice, something the drug has not typically been prescribed for. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2020 Category: International Medicine & Public Health Source Type: news

Rigorous Detection of Nitrosamine Contaminants in Metformin Products: Balancing Product Safety and Product Accessibility
Nitrosamines are a class of chemicals that commonly occur as impurities in water, beverages, and foods (particularly in cured and grilled meats). Although nitrosamines are generally regarded to be carcinogenic, small amounts of exposure are not considered to be harmful. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

SGLT2 Inhibitors With Metformin Do Not Up Fracture Risk SGLT2 Inhibitors With Metformin Do Not Up Fracture Risk
The combination of SGLT-2 inhibitors and metformin is not associated with an increase in fracture risk among patients with type 2 diabetes, according to a meta-analysis of 25 randomized, controlled trials.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 21, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Bayshore Pharmaceuticals, LLC, Short Hills, NJ is voluntarily recalling one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg, 1000 count bottles and one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 count bottles within expiry to the consumer lev (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Does Metformin Reduce Risk for Death in COVID-19? Does Metformin Reduce Risk for Death in COVID-19?
Observational study data suggest that metformin reduces the risk for death from severe COVID-19, but questions remain.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - August 14, 2020 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news

Does Metformin Reduce Risk for Death in COVID 19
Does Metformin Reduce Risk for Death in COVID-19? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 14, 2020 Category: General Medicine Source Type: news

A rare case of metformin intoxication with mortal course - Osoydan Satici M, Algin A, Aksel G, Ero ğlu SE.
Metformin-associated lactic acidosis is a rare side effect in metformin poisoning. There is conflicting data about mortality rates changing from 3% to 83%. We aimed to discuss a case that developed lactic acidosis and acute renal failure progressing to mor... (Source: SafetyLit)
Source: SafetyLit - August 4, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Dapagliflozin as add-on to metformin may reduce T2DM burden in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 31, 2020 Category: Drugs & Pharmacology Source Type: news

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2020 Category: Pharmaceuticals Source Type: news

Search list of recalled metformin products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 13, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis revealed that certain tested batches wer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Lupin recalls diabetes treatment drug in US
Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2020 Category: Pharmaceuticals Source Type: news